Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice.
Inamoto
Sakiko
S
Department of Internal Medicine III, Osaka Medical College, Takatsuki, Osaka, Japan.
Yoshioka
Toshitaka
T
Yamashita
Chika
C
Miyamura
Masatoshi
M
Mori
Tatsuhiko
T
Ukimura
Akira
A
Matsumoto
Chika
C
Matsumura
Yasuo
Y
Kitaura
Yasushi
Y
Hayashi
Tetsuya
T
D000447:Aldehydes / Q000097:blood; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000860:Hypoxia / Q000150:complications* / Q000503:physiopathology; D020287:In Situ Nick-End Labeling; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009206:Myocardium / Q000473:pathology; D018384:Oxidative Stress / Q000187:drug effects*; D011804:Quinolines / Q000627:therapeutic use*; D012891:Sleep Apnea Syndromes / Q000150:complications* / Q000503:physiopathology; D013851:Thinness / Q000503:physiopathology; D016212:Transforming Growth Factor beta / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D020257:Ventricular Remodeling / Q000187:drug effects*
D000447:Aldehydes; D000975:Antioxidants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011804:Quinolines; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol; C027576:4-hydroxy-2-nonenal; C108475:pitavastatin